Document Detail

Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease.
MedLine Citation:
PMID:  21377529     Owner:  NLM     Status:  Publisher    
Parkinson's disease (PD) has been linked to exposure to a variety of chemical (e.g., pesticides) and inflammatory agents, which may act cumulatively over time. Finding novel means of limiting pathology associated with toxin exposure would have tremendous clinical importance. To this end, we assessed whether the hematopoietic trophic cytokine, granulocyte macrophage colony stimulating factor (GM-CSF), would inhibit the neurodegenerative effects of the pesticide, paraquat, administered either alone or following priming with the bacterial endotoxin, lipopolysaccharide (LPS). As previously observed, paraquat provoked a modest but significant neurodegenerative effect that was markedly augmented with LPS priming. Central infusion of GM-CSF into the substantia nigra pars compacta (SNc) prevented the loss of SNc dopamine neurons to a degree comparable to that of glial derived neurotrophic factor. Importantly, systemic administration of GM-CSF also had neuroprotective consequences, suggesting that the trophic cytokine can cross the blood brain barrier to promote neuronal survival. Indeed, GM-CSF acted to inhibit the LPS and paraquat induced microglial response, while augmenting astrocyte immunoreactivity within the SNc. Moreover, GM-CSF blunted the paraquat induced reduction of brain derived neurotrophic factor within the hippocampus, as well as in cultured mesencephalic neurons. Although paraquat reduced mesencephalic levels of the anti-apoptotic protein, Bcl-2, GM-CSF had no effect in this regard. Hence, GM-CSF appears to affect inflammatory and/or neuroplastic factors within the SNc that may be linked to neurodegeneration, as well as in other brain regions (hippocampus), which could be important for co-morbid non-motor symptoms in PD. These data suggest that peripheral GM-CSF administration might hold promise as a treatment of PD.
E N Mangano; S Peters; D Litteljohn; R So; C Bethune; J Bobyn; M Clarke; S Hayley
Related Documents :
11776069 - Kinetic study of eosinophil apoptosis and its relationship to th2 cytokines in asthmati...
18673279 - The antipathogen activities of eosinophil cationic protein.
7734979 - Immunocompetent cells of the upper airway: functions in normal and diseased mucosa.
6692479 - Interactions between eosinophils and antibodies: in vivo protective role against rat sc...
7461719 - Suppression of antibody-mediated accumulation of eosinophils in chronic inflammatory le...
8793449 - Endobronchial secretion of interleukin-13 following local allergen challenge in atopic ...
24098319 - Correction: cigarette smoke-induced collagen destruction; key to chronic neutrophilic a...
25483139 - Immunoendocrine dysbalance during uncontrolled t. cruzi infection is associated with th...
14599779 - No caspase activation but overexpression of bcl-2 in bovine cells infected with noncyto...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-3
Journal Detail:
Title:  Neurobiology of disease     Volume:  -     ISSN:  1095-953X     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9500169     Medline TA:  Neurobiol Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Insecticidal effect of Canavalia ensiformis major urease on nymphs of the milkweed bug Oncopeltus fa...
Next Document:  Transcriptomic responses to functional feeds in Atlantic salmon (Salmo salar).